The effect of SARS-Co-V2 infection on prothrombotic and anticoagulant factors in dialysis patients.

Anne RiddellPratima ChowdaryAndrew Davenport

Published in: Artificial organs (2022)

COVID-19 dialysis patients have increased levels of fibrinogen and D-Dimers, but only factor VIII levels in the clotting profile increased with clinical disease severity increasing systemic hypercoagulability. AT concentrations are maintained and as such should not compromise anticoagulation with heparins.

Keyphrases

end stage renal disease
chronic kidney disease
peritoneal dialysis
ejection fraction
newly diagnosed
atrial fibrillation
prognostic factors
sars cov
coronavirus disease
patient reported outcomes
patient reported